> Skip repeated content

Biomarkers Linking SLE-Associated Pulmonary Arterial Hypertension

Rheumatology Advisor—June 16, 2017

In an article on Cardiology Advisor, a recently published study linked a higher cause of death for people with systemic lupus erythematosus (lupus) and pulmonary arterial hypertension (PAH), compared to the general lupus population.

Early recognition for pulmonary arterial hypertension is important, however it is difficult to detect. This is due to patients not exhibiting cardiopulmonary symptoms until they are already in the advanced stages, noted by the authors of the study.

Michael D. Lockshin, MD, rheumatologist at HSS, commented on how to detect PAH as soon as possible. "It is advisable to monitor patients, especially those who have the noted characteristics...every 2-3 years."

He added, "other than recognizing those patients at highest risk, we don't have a good way to predict exactly who will develop pulmonary hypertension, so there is a need to identify even better predictors so that we can prevent this complication."

Read the full article at thecardiologyadvisor.com


Need Help Finding a Physician?

Call us toll-free at:

Media Contacts


Social Media Contacts